French biomedical aesthetic company Noveau Visage hosted press and practitioners at the Bvlgari Hotel, London, on May 12.
The event kickstarted with networking, giving attendees and specialty figures the opportunity to reconnect and discuss the launch of the NEWDERM range, which offers five targeted protocols addressing ageing, pigmentation, eye concerns, hair loss and skin laxity.
The talk began with founders of Noveau Visage, Carlos Royo Pérez and Casper Henrique Tingkaer, introducing the brand and NEWDERM range. Next, plastic surgeon and key opinion leader Mr Apostolos Vlachogiorgos outlined clinical protocol and suitability. Finally, Shaunagh Durkin, commercial director at Fox Pharma – one of the four distributors of Noveau Visage – provided insight on commercial opportunities.
Royo commented, “The UK aesthetics market continues to move rapidly towards regenerative and biologically-driven treatments, and Nouveau Visage represents a significant step forward within this space, offering an innovative and versatile treatment portfolio for discerning clinics. We are excited to be launching in the UK and adding this market to our growing list of territories – and we look forward to working closely with aesthetic practitioners, clinics and pharmacy partners to support this exciting rollout.”